About
1.82CAD+0.01 +0.55%
Closed • Updated at 23:59 GMT+00:00Market Cap$147.72M
Volume50.8K
Beta1.96
RSI49.89
Cardiol Therapeutics Inc. Class A — investor relations, events, news, and company updates on 6ix.
Latest News
May 14 2026
Cardiol Therapeutics to Participate in Fireside Chat at H.C. Wainwright 4th Annual BioConnect Investor Conference at the NASDAQ
May 7 2026
Cardiol Therapeutics' Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association
Apr 28 2026
Cardiol Therapeutics Expands U.S. MAVERIC Phase III Trial Network to Address Growing Interest in the Pivotal Program
Apr 14 2026
Cardiol Therapeutics to Highlight MAVERIC Phase III Trial and Recently Published ARCHER Results in Live Interview with Barchart
Apr 1 2026
Cardiol Therapeutics Announces Year-End 2025 Update on Operations
Community Chat
Ask AI
Try asking
Google Übersetzer